$13.80
0.665.02%
Últ. Act.: Oct 20, 4:34 PM
$13.80
0.665.02%
AVITA Medical (RCEL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
AVITA Medical (RCEL) publicó su última previsión de agosto 6, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $86M - $89M para el período.
En comparación con la previsión anterior, AVITA Medical elevado redujo su previsión de ingresos desde un rango anterior de $80M - $85M.
AVITA Medical ha emitido 38 actualizaciones de orientación entre el noviembre 10, 2022 y el agosto 6, 2026. During this period, the company raised its outlook 7 times and lowered it 18 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.38 | $-0.47 | $-0.44 |
| Actual | $-0.25 | $-0.35 | $-0.38 | $-0.46 |
| Surprise | +32.4% | +7.89% | +19.1% | -4.55% |
| Revenue | ||||
| Estimate | $28.6M | $24.3M | $25.2M | $27.7M |
| Actual | $21.7M | $19.3M | $17.6M | $16.9M |
| Surprise | -24.1% | -20.9% | -30.2% | -39.0% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.29 | $-0.24 |
| Revenue | ||
| Consensus | $31.8M | $34.2M |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.25 | $-0.37 | 32.4 % |
| Q1 | May 14, 2026 | $-0.35 | $-0.38 | 7.89 % |
| Q4 | Feb 12, 2026 | $-0.38 | $-0.47 | 19.1 % |
| Q3 | Nov 6, 2025 | $-0.46 | $-0.44 | -4.55 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $21.70M | $28.59M | -24.1 % |
| Q1 | May 14, 2026 | $19.25M | $24.33M | -20.9 % |
| Q4 | Feb 12, 2026 | $17.62M | $25.23M | -30.2 % |
| Q3 | Nov 6, 2025 | $16.90M | $27.70M | -39.0 % |